CLINICAL_TRIALS
trial_result
· 2012-04-12
Clinical Trial Update: Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis [Phase 2, Phase 3]
Summary
A phase 2/3 trial evaluating budesonide versus placebo for lymphocytic colitis has been terminated; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Lymphocytic Colitis, Diarrhea | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2012-04-12